Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Stock Quote Today & Recent News Immunoprecise Antibodies Ltd IPA

ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industrial community. The company has aggregated its operations into one reportable segment, Antibody Production, and Related Services. It operates in three principal geographical areas - the United States of America, Canada, Europe, and others. The majority of its revenue is derived from the United... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Current News (NDAQ:IPA)

ImmunoPrecise Antibodies And InterSystems Partner To Leverage AI In Life Sciences, Transforming Patient Care With Accelerated Discovery And Delivery Of Treatments

Accesswire 5 days ago

InterSystems and IPA's Subsidiary BioStrand Collaborate to Unveil the Innovative Integration of Vector Search with LENSai for AI-Driven Healthcare Applications

Business Wire March 28, 2024

IPA Acquires the Carterra LSA® Instrument to Enhance Antibody Discovery and Bolster Its AI Developments

Business Wire March 20, 2024

IPA Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024*

Business Wire March 14, 2024

ImmunoPrecise Antibodies (NASDAQ:IPA) Subsidiary BioStrand Introduces Breakthrough AI Model In Life Sciences, Harnessing LLM Stacking And HYFT Technology

Accesswire March 8, 2024

IPA's subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology

Business Wire March 7, 2024

IPA to Report Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2024 on March 14, 2024

Business Wire March 4, 2024

ImmunoPrecise Antibodies (NASDAQ:IPA) Is Changing How We Look At The Complex World Of Antibody Discovery

Accesswire February 13, 2024

ImmunoPrecise Antibodies Reports A 19.9% Revenue Increase As It Launches The Next Phase Of LENSai Portal And SaaS Platforms

Accesswire January 10, 2024

Opinion & Analysis (NDAQ:IPA)

No current opinion is available.

Bullboard Posts (NDAQ:IPA)

ImmunoPrecise Antibodies (NASDAQ:IPA) Subsidiary BioStrand I

JUST IN: $IPA ImmunoPrecise Antibodies (NASDAQ:IPA) Subsidiary BioStrand Introduces Breakthrough AI Model In Life Sciences, Harnessing...
whytestocks - March 8, 2024

Nice volume! Great news

Just when you think they were a dog with fleas they find ways to be awesome. I think I'm going for a ride again.
GoldenArm1 - March 7, 2024

IPA's subsidiary BioStrand Unveils Major Breakthrough in Lif

Just In: $IPA IPA's subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM...
whytestocks - March 7, 2024

Blog post yesterday.

Biostrand, which is IPAs wholly owned AI division, announced that it's AI (silico) can match the standard wet lab (vivo) in drug...
wallpaper2 - February 29, 2024

RE:Another release today.

In the section "Validated Agreements" we are in the "Near Perfect" range. Read what their "GOAL" is! &...
wallpaper2 - February 7, 2024

Another release today.

Can't be much clearer than that. 
wallpaper2 - February 7, 2024